과학
중도 성향
STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment
STAT News
Regulators at the FDA have reiterated concerns that Replimmune does not have adequate data to support an approval of its investigational skin cancer treatment. ...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
Global hotspots where drought poses the greatest threat to crop production mapped
Phys.org
A potential sleep crisis among workers over 50: Study links work-related stress to range of well-being issues
Medical Xpress
New theory on how six‑tonne Stonehenge rock was transported from Scotland thousands of years ago: On a glacier
Phys.org